NCT03108066
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
VHL Syndrome
Explore clinical trials studying VHL Syndrome. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
VHL Syndrome trial results
Active, Not Recruiting
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
NCT06195150
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +26 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Active, Not Recruiting
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
NCT03401788
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States